Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
Active, not recruiting · NCT04938609 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC) | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 2 | 2026-04-09 | NCT04938609 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Providence Cancer Center, Earle A. Chiles Research Institute | 6 |
| Providence Health & Services | 35 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Portland Providence Medical Center | Portland | United States | 4 |
| Providence St. Vincent Medical Center | Portland | United States | 35 |
| University of San Diego | San Diego | United States | 1 |